Part,  Chapter, Paragraph

 1    I,     2. 10.  2|        various colours. Used for cell imaging, in particular in
 2   II,     5.  9.  4|        PLN responses (weight and cell number) to Ova and ambient
 3   II,     5.  9.  4|     developing an in vitro human cell model in which to study
 4   II,     5. 11.Acr|             Acronyms~ ~BCC~Basal cell carcinoma~CEHAPE~Children’
 5   II,     5. 11.Acr|         skin cancer~SCC~Squamous cell carcinoma~ ~
 6   II,     5. 11.  3|         skin: melanoma, squamous cell carcinoma, some types of
 7   II,     5. 11.  3|        of skin lymphomas, Merkel cell tumours and others (See
 8   II,     5. 11.  3| non-melanoma (basal and squamous cell carcinoma) skin cancer (
 9   II,     5. 11.  3|        rate is over 2% for basal cell carcinoma (BCC) in males,
10   II,     5. 11.  3|        in males, 1% for squamous cell carcinoma (SCC) and over
11   II,     5. 11.  3|         Smans, 2003).~Both basal cell carcinoma and squamous cell
12   II,     5. 11.  3|      cell carcinoma and squamous cell cancer are cured by adequate
13   II,     5. 11.  4|      skin cancers such as Merkel cell tumours, malignant fibrous
14   II,     5. 11.  7|      incidence rates of squamous cell carcinoma of the skin in
15   II,     5. 15.  1|    syndrome, Hemophilias, Sickle cell disease, Cystic fibrosis
16   II,     5. 15.  4|        rules to facilitate gene, cell and tissue-based therapies
17   II,     9.  3.  2|       other method where the egg cell is fertilised outside the
18  III,    10.  2.  1|    larynx~- Oesophagus (squamous cell and adenocarcinoma)~- Stomach~-
19  III,    10.  2.  1|           renal pelvis and renal cell carcinoma)~- Uterine cervix~-
20  III,    10.  2.  1|          latter to penetrate the cell. Therefore, vitamin B12
21  III,    10.  4.  2|       Food and Feed~SCNT~Somatic Cell Nuclear Transfer~TOFMS~Time
22  III,    10.  4.  2|        animal cloning by somatic cell nuclear transfer (SCNT)
23   IV,    11.  5    |                    11.5. Tissue, cell and organ transplants~ ~
24   IV,    11.  5.  5|       common issues in organ and cell transplant in order to join
25   IV,    11.  5.  5|     transplant therapies,~2. new cell therapies for CSE and solid
26   IV,    11.  6.  5|      2007): European research on cell and organ transplantation:
27   IV,    12. 10    |  Embryonenschutzgesetz) and Stem Cell Act (Stammzellgesetz). Further